. 2019 Nov 19;10(6):e02774-19. doi: 10.1128/mBio.02774-19

TABLE 1.

CF sputum samples used in this study

Human sputum sample	Source	Total no. of reads	No. of reads mapped to:		MSSA or MRSA^a	Recent sputum microbiology^b
Human sputum sample	Source	Total no. of reads	S. aureus	mecA	MSSA or MRSA^a	Recent sputum microbiology^b
EM3	GA, USA	54,478,195	2,569,031	4,674	MRSA	MSSA, P. aeruginosa
EM13	GA, USA	77,035,116	990,342	474	MRSA	P. aeruginosa
EM15	GA, USA	110,756,562	622,666	15	Likely MRSA	Achromobacter, MSSA
EM18	GA, USA	50,839,416	456,406	38	Likely MRSA	Achromobacter, MSSA
EM22	GA, USA	29,554,488	405,887	6	MSSA	MSSA
EM47	GA, USA	49,914,107	1,288,259	128	MRSA	MSSA
EM48	GA, USA	56,958,617	1,239,803	28	Likely MRSA	MSSA, P. aeruginosa
EM58	GA, USA	123,479,263	960,385	22	Likely MRSA	Burkholderia cepacia, MRSA, P. aeruginosa
EM61	GA, USA	78,248,618	193,333	5	MSSA	MSSA, P. aeruginosa
G	Denmark	78,869,961	624,172	48	Likely MRSA	P. aeruginosa, S. aureus

MRSA and MSSA designations were determined by the number of S. aureus reads mapping to mecA in a pangenome of 12 S. aureus strains. Strains were designated “likely MRSA” if >10 reads mapped to mecA and MRSA if >100 reads mapped.

Recent sputum microbiology is the associated clinical microbiology culture metadata for the sample.